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0006-4 9 71 /93/8 1 0 7-0024$3.00/0 from the vessel adventitia, and radiate in the BM cavity. Long-term BM culture (LTBMC) in vitro contain LNGFR+ stromal cells. We document the presence of RNA message for the low-(LNGFR) and the high-affinity NGF receptor (NTRK1) by using RT-PCR on fresh BM aspirate and on LTBMC. BM biopsies from patients with hematologic fibrogenic diseases and in cytokine-treated cancer patients are evaluated for LNGFR + cells: the amount of stained cells is correlated with the traditional reticulin stain in cases of myelofibrosis, therapy-related myelodysplasia, leukemia, and detected an increase of stromal cells in cytokine-treated patients. The anti-LNGFR antibodies represent a specific membrane marker for the adventitial reticular cells (ARC) of the human marrow and allow precise evaluation and quantitation of this important BM microenvironment component in vivo and in vitro. vivo is based on the demonstration of endogenous alkaline phosphatase by the ARC and on the deposition of various extracellular matrix proteins such as collagens, laminin, and fibronectin.'0-14 However, none of the above-mentioned markers is neither specific nor restricted to a given BMS lineage: alkaline phosphatase can be found on ARC and endothelial cells as we11.I5 Reticulin silver staining, a long-established method to stain the extracellular collagenous BM matrix, is not specific for a given collagen type. 16 Collagenspecific antibodies are useful but the extracellular location of the collagens does not allow the identification of one cell type when two cells are juxtaposed.
Positive recognition of BM fibroblastic cells by phenotype is feasible in rats,17 but equivalent markers for humans are still lacking.
An antibody directed against the low-affinity nerve growth factor receptor (LNGFR or p75NGFR)18.'9 was shown to label a subset of BM mesenchymal cells during an extensive immunohistochemical investigation of normal tissues. Staining of mesenchymal cells by an anti-NGF-R monoclonal antibody (MoAb) has been reported previ~usly,~'-~~ but little attention has been paid to the BM staining, although this latter tissue was investigated."
In view of the usefulness of a specific and restricted marker for the BM ARC, we have characterized the BM cell population stained by the anti-LNGFR antibody by light and electron microscopy, cell culture, and molecular biology methods and we have compared this newly described marker with the established stains for the BM stroma.
PATIENTS
Three groups of patients were investigated: patients with hematopoietic disorders, patients with nonhematopoietic tumors metastatic to the marrow, and cancer-bearing patients with a normal marrow treated with cytokines.
Fourteen patients had therapy-related myelodysplastic syndromes For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From lymphoma [NHL], 2; breast carcinoma, 2; multiple myeloma, 1; basal cell carcinoma, I). Five additional patients had leukemia (2 acute myelogenous leukemia, 1 chronic myeloid leukemia, 2 hairy cell leukemia). Two had primary idiopathic myelofibrosis.
BM biopsy samples from three breast carcinoma patients with involved marrow were obtained during the staging procedures.
Nine patients with solid tumor (breast cancer, 6, Hodglun's disease, I; NHL, 2) and uninvolved marrow were treated with high-dose cyclophosphamide (HD-CTX) (7g/m2) followed by recombinant interleukins (ILs) for 10 to 18 days (recombinant human granulocytemacrophage colony-stimulating factor [rhGM-CSF], Sandoz, Basel, Switzerland, 5.5 pg/kg/d rhlL-3, Sandoz, three groups receiving I .O, 2.5, and 5 pg/kg/d). BM trephine biopsy samples were taken shortly before the HD-CTX administration and after hematopoietic recovery from chemotherapy-induced pancytopenia, between I and 6 days after cytokine discontinuation.
The control group included three patients with Hodgkin's disease from whom a BM biopsy was available, and who had been treated with HD-CTX without any subsequent cytokine treatment.
The clinical and hematologic characteristics of these patients have been published p r e v i~u s l y .~~ Normal BM trephine biopsies were obtained with a Jamshidy needle during the staging procedures for suspected lymphoma ( I patient with reactive lymphadenopathy), breast carcinoma ( 1 patient), and from 1 BM donor, or from resected pelvic uninvolved bone of soft tissue sarcoma patients undergoing hemipelvectomy. In any case, informed consent was obtained from the patient before the diagnostic BM biopsy of surgery. The BM was free of disease, except when indicated. BM from six fetuses, 12 to 18 weeks gestational age, was obtained from legally aborted fetuses as previously de~cribed.'~
BONE MARROW BIOPSIES
Triplicate samples from resected bone were either snap frozen or fixed in formalin as follows: one biopsy was fixed in 10% buffered formalin for 4 hours, decalcified in 10% Titriplex (Merck, Darmstad, Germany) overnight, and embedded in paraffin. A second sample was fixed and decalcified as above and then soaked overnight at 4°C in a mixture of gum acacia (Merck) 10 g, sucrose (Merck) 300 g in Trisbuffered saline (TBS) 0.05 mol/L pH 7.6 (modified from26). Then the biopsy was covered with OCT compound (Miles Inc, Elkhart, IN) and snap frozen in liquid nitrogen precooled isopentane (BDH, Poole, UK). A third sample was frozen unfixed and undecalcified.
A fresh human normal lymph node was similarly processed in parallel as a control of the immunoreactivity (not shown). This procedure ensured that all the antibodies used with two exceptions (vide infra) equally reacted with both types of frozen material.
Five-micrometer sections were cut from the paraffin block, dried overnight at 37°C on polylysine-treated (Sigma, St Louis, MO) glass slides, deparaffinized in xylol, and brought to water through a graded alcohol series. Trypsin treatment (0.05% trypsin, 1% CaC12, 15 minutes at 37°C) was performed when needed. Frozen sections from the undecalcified biopsy were dried thoroughly and fixed briefly in acetone (Merck) or thaw-fixed in buffered 10% formalin for 10 minutes before immunostaining. Prefixed, decalcified cryostat sections were collected on polylysine-treated slides and immediately thawed in TBS. Prefixed, decalcified frozen BM biopsies had an excellent morphologic detail, superior to snap frozen sections, although loss of the bony spiculae frequently occurred moreover, a few antigens did not survive formalin fixation per se (eg, Thy-1, PAL-E). Because of that, evaluation on both type of frozen sections and on smears was routinely compared.
BM smears were air dried and fixed in acetone or 10% formalin as above.
LONG-TERM BM CULTURES (LTBMC)
LTBMC were established from I 1 different healthy donors as previously described by Gartner and &plan2' with minor modificationF8 Briefly, red blood cell (RBC)-depleted BM aspirates (1.5 to 2 X lo6 mononuclear cells/mL in 10% preselected fetal calfserum (FCS) (Flow Laboratories, Irvine, Scotland), 10% horse serum (HS) (GIBCO, Grand Island, NY), 5 X hydrocortisone sodium succinate (Sigma), and lscove's Modified Dulbecco's Medium [IMDM; GIBCO]) were inoculated in 25-cm2 tissue culture flasks (Nunc, Roskilde, Denmark).
The flasks were gassed with 5% C 0 2 in air, sealed and incubated at 33°C. At weekly intervals the cultures were demipopulated, and half of the medium was replaced by fresh growth medium. At different culture times (2,4,7, and 8 weeks) the adherent cell layer was detached from the flasks by enzymatic treatmentz9 Then the cells were cytocentrifuged and stained as previously described.29
The cultures to be analyzed in situ were fixed in paraformaldehyde 4% for 6 hours at 4"C, then gently detached from the flask, encased in a thin agar slice, dehydrated in alcohol, and embedded in paraffin.
MATERIALS AND METHODS
Immunohistochemistry. The sections were covered with decomplemented AB serum, blotted, incubated overnight with the antisera (Table l) , washed twice in TBS, and counterstained with the APAAP (Dako, Glostrup, Denmark) method3' for MoAbs and with Streptavidin-conjugated alkaline phosphatase (Malta, Milano, Italy) via a biotin conjugated secondary antibody (Vector, Burlingame, CA) for the goat and rabbit sera.
In selected cases the sections were treated with hydrogen peroxide 0.3%, sodium azide 0.1% in phosphate-buffered saline (PBS) pH 7.5 for 30 minutes to abolish endogenous peroxidase, and stained with the avidin-biotin peroxidase complex (ABC)
The endogenous alkaline phosphatase (AlkPh), acid phosphatase (AcPh), and a-naphtyl acetate esterase (aNAE) were stained on formalin postfixed (10% formalin, 10 minutes) frozen sections and smears with Fast Blue BB diazonium salt (Sigma) as a developer, according to Hayhoe and Q~a g l i n o .~~ The slides were subsequently immunostained with the APAAP method in red, when required. If a combination of contrasting colors is used (ie, blue and red), the two colors can be easily appreciated when on two separate cell types. If the enzyme and the antigen are located on the same structure, a mixed pink color may be obtained. Adenosine triphosphatase (ATPase) cytochemical stain was performed with the lead method, according to Robins and B r a n d~n . '~ Formalin-fixed, paraffin-embedded sections were stained for reticulin with the Gomori's silver stain method. 35 Paraffin sections that were immunostained with three rounds of APAAP and red newfuchsin development could be subsequently stained for reticulin.
Immunohistochemical reactivity was expressed as a percentage of stained cells on the total number of BM nucleated cells as previously published.24 Cells were counted at 1,OOOX magnifications with a 10 mm X 10 mm ocular gnd on areas measuring at least 10 mm2, excluding cortical and trabecular bone, fat, periostal connective tissue, and areas of hemorrhage. The reticulin content of the marrow was graded according to the scoring system proposed by Manoharan et Double and triple immunofluorescence was performed on acetone-fixed frozen sections and BM smears and on reference tissues (lymph node, kidney, liver, skin, etc) as a control. Mixture of two or three primary antibodies raised in different species or of different mouse Ig isotype were incubated on the slide for 1 hour, washed thrice with PBS, 5% bovine serum albumin solution (PBS-BSA, to which sodium azide 15 mmol/L and Triton X-100 0.005% was added) and counterstained with a mixture of isotypeai. 35 ImmunoJuorescence.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From BM spiculae were picked up with thin-tips tweezers from sodium citrate anticoagulated BM aspirate, prefixed with 0.2% glutaraldehyde in PIPES buffer for 5 minutes, rinsed in PBS, and finally treated for 20 minutes with 1 % glycine in PBS. The spiculae were then incubated with PBS Immuno-electron microscopy.
containing 10% decomplemented AB serum, 10% normal goat serum, BSA, with the anti-LNGFR MoAb at the appropriate dilution and finally with goat anti-mouse Igs coupled with 15 nm colloidal gold particles (GAM-1 5; Janssen, Beersee, Belgium). The samples were then dehydrated in graded alcohols and propylene oxyde, embedded in an Epon Araldite mixture, and thin sections examined at 80 kV with a Philips 4 I O transmission electron microscope. Two LTBMC and a fresh BM aspirate from a hematologically normal donor were lysed in 4 mol/L guanidinium isothiocyanate for RNA extraction. Total RNA was prepared by cesium chloride gradient and reverse transcribed using 0.5 pg of oligo dT primer (Clontech Laboratories Inc, Palo Alto, CA, purchased from Technogenetics, Milano, Italy) and MMLV-RT (Bethesda Research Laboratories, Gaithersburg, MD) for 2 hours at 42°C. Two microliters of cDNA was used for amplification of P-actin (Clontech), to check for effective cDNA synthesis, according to the protocol provided by the manufacturer. For amplification of LNGFR and NTRKl the primers were, respectively, the direct 5'-GACAGTGGCATCTCCGTGGACCA-3' (position 1023 through 1044), and reverse 5'-ACACCGGGGATG-TGGCAGTGGA-3' (position 1343 through 1395) according to LNGFR published sequences36 and the direct 5'-CCCAATGCCT-CGGTGGATGTGG-3' (position 685 through 706), the reverse 5'-
RNA isolation and reverse transcriptase-PCR (RT-PCR).
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From AAGGGTTGTCCATGAAGGCAGCC-3' (position 12 IO through 1231) of the NTRK1." After 30 and 40 cycles of amplification, 8 of 50 pL of the PCR product were run on a I .5% agarose gel and transferred to nylon filters by alkaline blotting and hybridized with "Plabeled internal oligos.
As a positive control for LNGFR and NTRKI expression, cDNA was obtained from the neuroblastoma cell line IMR-32 (American Type Culture Collection No. CCLl27; Rockville, MD).
RESULTS

LNGFR staining ofnormal BM.
A dense meshwork of reticular cells was stained by both anti-LNGFR antibodies in the BM, both in frozen and in formalin-fixed, paraffinembedded biopsies (Fig I . A and 9 ). The positive cells had an oval nucleus, a triangular cytoplasm, and long, thin, branching dendrites that intermingle with the hematopoietic cells, encircle the periphery of the adipocytes and line the endoosteal surface of the bone trabeculae. The immunostained dendrites were found at the abluminal surface of the littoral (vascular sinus endothelial) cells, and made the wall of the vascular sinus, mostly together with a thin endothelial cover (Fig 19) . Larger capillaries and BM vessels had an LNGFR+ve adventitial coat. Endothelium was found to be negative with no exceptions. No distinction between axial and paratrabecular BM parenchyma was noted, as far as LNGFR+ve cell presence was concerned.
All kinds of hematopoietic cells had intimate contact (ie, membrane fusion at light microscopy) with the extensively branched LNGFR+ve dendrites, including approximately half of the CD34+ve lymphoid-looking cells (by double LNGFR and CD34 staining). A portion of the megakaryocyte periphery was frequently embraced by an LNGFR+ve dendrite (Fig IA) .
In the fetal BM, the LNGFR+ve cell population was composed of a fibrous adventitial layer around the central vessel, and a spongy dendritic meshwork parallel to the vessel axis which spread in the BM parenchyma (Fig IC) . Osteoblasts were not stained. The empty marrow spaces at the epiphyseal end of the developing BM cavity were filled with scattered LNGFR+ve fibroblasts. The network of stained cells in the fetal BM cavity is more dense around the central vessel: how- 
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ever, the representation of the LNGFRfve population at the paraosteal or interstitial side of the adult hematopoietic marrow was equal and its distribution was unaffected by the change in BM cellularity (not shown).
On BM smears, LNGFR+ve fibroblastoid cells had a ruffled membrane outline and two opposite dendrites of 43.9 k 26 pm length (46 cells counted from 6 BM) (Fig 1, D and The presence of a villous membrane outline was characteristic of the positive cells, even when the dendrites were small or unremarkable. Fragments of the positive dendrites were seen on the smear, but never adherent to hematopoietic cells. The vast majority of ARC were entrapped in the marrow fragments and displaced toward the edge of the smear: therefore, quantitation was not attempted.
No other cell type was stained by the LNGFR antibodies in the BM but two: on sections, small nerva vasorum endings in the larger vessel wall were stained.
In BM smears from pediatric patients, a population of monocytoid, small-to-medium sized leukocytes with a regular membrane outline, a kidney-shaped or indented nucleus, and a gray cytoplasm (dimly LNGFR+ve, CD45+ve, vimentinfve, IgD-ve, CD3-ve, alkaline phosphatase-ve, acid phosphatase-ve, acetate esterase-ve) averaging 0.05% of BM leukocytes was detected (Fig 1D) . These cell types were not further investigated.
Five antibodies (vimentin, collagen III"," TE-7,3s Thy-I , 39 and CD 1 340) known to recognize mesenchymal cells, decorated a meshwork of reticular cells interspersed within the BM parenchyma, with a staining pattern superimposable to the LNGFR; in addition, they reacted to a variable extent with adipocytes, endothelium, and hematopoietic cells (not shown). Endothelium-associated antigens recognized by The identity of the LNGFR+ve cell population with the so far described ARC in the BM was checked by a doubleand triple-staining approach: LNGFR was assayed versus either established markers for BM stroma or antibodies shown to selectively identify a given cell lineage (eg, endothelial, fibroblastic, etc).
Silver reticulin staining colocalized with the receptor, ie, no LNGFR+ve, reticulin-negative cells were observed (Fig  2) . However, reticulin deposition was in excess of the LNGFR and was found on the adipocyte basal membrane and lining the BM sinuses.
A population of dendritic fibroblastoid cells with identical morphology, size, and frequency as the LNGFR+ve population was stained on BM smears and sections by AlkPh and ATPase, but not by AcPh, aNAE. The identity between these cell subsets and LNGFRfve cells was confirmed by double staining. The endogenous AlkPh+ve population overlap completely with the LNGFRfve one, with the exception of endothelia and a few neutrophils (LNGFR-ve). On the contrary, double staining for CD45 and AlkPh, CD68 and AlkPh, E).
AcPh and LNGFR, and aNAE and LNGFR showed nonoverlapping cell subsets. Double immunofluorescence (IF) staining on frozen BM sections and smears showed that the LNGFR+ve cells lack the CD45 molecule, as determined by MoAbs directed against common and restricted leukocyte common antigen epitopes (Fig 3) . The dendritic cells had a prominent cytoplasmic vimentinSve cytoskeleton. Endothelial markers (vWF, CD34, PAL-E) were absent on the LNGFRfve BM cells, as assessed with double and triple immunofluorescence on smears and frozen sections.
Single and double immunohistochemical staining showed no evidence of neurofilament or neural cell adhesion molecule (N-CAM/CD56) positivity of the reticular cells. The latter molecule was present on the endoosteal fibrous tissue surrounding the bone and on the nerva vasorum (not shown).
The double-staining experiments, both in IPX and IF, showed a close juxtaposition of LNGFRfve, collagen IV"+ve, and IamininSve structures at the adipocyte periphery and in scattered points of contact with the endothelial (littoral) cells within the EM parenchyma (Figs 4 through 6 ). There, Pal-E+ve CD34+/-ve endothelia formed trilaminar structures with the basal lamina (laminin+ve) and the adventitial reticular cells (LNGFR+ve) (Fig 5) .
Large vessels and capillaries had a laminin+ve, collagen IVo+ve basal membrane embraced by the adventitial cuff of LNGFR+ve fibroblasts (Fig 5) .
Double IF staining for LNGFR and collagen 111" showed coexpression of both to a large extent (Fig 6) . However, LNGFR stained the cell membrane (which was collagen 111' -ve); coexpression was limited to the dendrites. Collagen III"+ve LNGFR-ve structures were also found.
EM identification of LNGFR+ve BMS cells. LNGFR+ cells were rare in the BM fragments examined and were seen surrounded by hematopoietic cells or in close apposition with either sinus endothelial cells or adipocytes or megakaryocytes. The LNGFRS cells had generally a very elongated shape with an oval nucleus and a scanty cytoplasm containing abundant well-developed Golgi apparatus in the perinuclear region, rough endoplasmic reticulum, mitochondria, bundles of microfibrils, and vacuoles. At the cell extremities the cell membrane was generally extremely ruffled with numerous elongated thin dendrites departing from the cell body (Fig 7A) . These dendrites were either in contact with hematopoietic cells or surrounding the abluminal side of the sinusoids; direct contact between LNGFR+ dendrites and endothelial cells was never observed, with the extracellular matrix always present in between (Fig 7B) . The gold marker, labeling the LNGFR, showed an intense and even distribution both on the cell body and on the dendrites with no specific localization at sites of cell contact.
Anti-LNGFR MoAbs labeled a population of fibroblastoid cells with a ruffled membrane outline (Fig 8A) in LTBMC starting from the fourth week of culture on; 7% to 1 I % of the cells were stained, the remaining cells being LNGFR-ve fibroblasts and macrophages. On sections, the antibodies highlighted isolated bipolar cells with long dendrites, mostly located in the middle of the adherent
In vitro cultured BM.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From For personal use only. on October 3, 2017. by guest www.bloodjournal.org From stroma (Fig 8B) . particularly in areas where a growing capillary vessel can be found by light microscopy and immunohistochemical staining.
The distribution of LNGFR on the BM stroma was evaluated on three types of BM specimens: patients with myeloproliferative syndromes,
Fibrotic and postchemotherapy BM.
patients with solid tumors metastatic to the marrow, and patients who were cytokine treated (GM-CSF, IL-3) and control patients recovering from HD-CTX.
In all cases of leukemic or metastatic marrow examined the reticulin deposition and the LNGFR stain showed a parallel concordant increase ( Table 2 ). Coexpression of both For personal use only. on October 3, 2017. by guest www.bloodjournal.org From could be demonstrated by double-reticulin and LNGFR staining in 20 tested cases.
The endothelial cells (identified by CD34 staining) were similarly increased in patients with acute and chronic leukemias, hairy cell leukemia, myelofibrosis and metastasis, and in 2 of 14 patients with myelodysplasia (Table 2) .
Statistical analysis of the semiquantitative reticulin and LNGFR scores and of the CD34 endothelial staining (CD34e) on the whole population studied showed that LNGFR and reticulin staining were strictly related (P c .03), while reticulin versus CD34e and LNGFR versus CD34e were not (P = not significant).
The BM biopsies with metastatic cancer had a reticulin staining more prominent than the LNGFR' population.
In patients treated with highdose chemotherapy and recovering from the aplasia either spontaneously (3 control patients), or with rhGM-CSF (3 patients) and rhlL-3 (6 patients), a posttreatment increase of LNGFR+ve reticular cells and of reticulin stain could be shown in all cytokine-treated patients, but not in the controls. rhlL-3 patients had a posttreatment increase in the LNGFR+ population without concomitant increase in the reticulin staining. In these patients, occasional LNGFRSve reticular cells were found positive for the proliferation-associated nuclear proliferating cell nuclear antigen (PCNA)46 (not shown).
The cytokine treatment increased the amount of endothelial cells in all cases, both with respect to the controls and to the pretreatment BM.
Moleciilar analwis of in vivo and in vifro BM.for NGF high-and Iow-afinif~~ recepfors. RNA from LTBMC and fresh BM aspirate was reverse transcribed and the resulting cDNA amplified with LNGFR. NTRKI, and B-actin primers. As control we used total RNA, from all the samples, as template for PCR to exclude DNA contamination (not shown). In addition, digestion of neuroblastoma IMR-32 cDNA with Hind111 endonuclease, which is expected to cut inside the amplified products, was performed to confirm the specificity of the primers. Figure 9 shows an agarose gel stained with ethidium bromide and loaded with the amplified product of LNGFR and NTRKI uncut (lanes 1 and 3, respectively) or after digestion with Hindlll ( lanes 2 and 4, respectively) . The uncut products were of the expected size (373 and 547 for LNGFR and NTRKI, respectively) such as were the bands resulting after Hindlll digestion (237 and 136 for LNGFR and 280 and 267 for NTRKI). Southern blotting and hybridization of LTBMC and fresh BM amplified cDNA showed that both LNGFR and NTRKI genes were expressed (Fig   IO) . However, PCR is not quantitative, and the comparison between the products resulting from 30 and 40 cycles of amplification shows that LNGFR. but not NTRKI, is less expressed in fresh BM than in LTBMC.
For LNGFR sraining ofsiromal cells in nonhematopoieIic tissiim and Ij~mphoid organs. Staining of stromal cells (ie, nonneural, non-epithelial) was restricted to a subset of fibroblasts in peculiar anatomical location (Table 3) : fibrous capsulae and vessel adventitia in all organs investigated. In the lymph node sinuses, spleen red pulp, liver sinusoids, kidney glomerulus, and in the developing capillaries of the fetal skin, LNGFR+ve fibroblasts were found apposed to the abluminal side of sinusoids and small capillary vessels (not shown).
DISCUSSION
The anti-LNGFR (~7 5~~~) antibodies Me20.4 and Me82 I 1 label a population of stromal BM cells of dendritic aspect that by the light and electron microscopic characteristics and by phenotype is completely superimposable to the cell population so far called ARC: PAS, PAA, and ISR.' These cells are responsible for the deposition of reticulin and collagen 111' and belong to the nonhematopoietic, mesenchymal lineage. The spatial distribution of the LNGFR+ve stromal cells within the BM microenvironment and their intimate relationship with littoral cells, adipocytes, capillary vessels, and BM hematopoietic elements, as described here, recapitulate identical findings previously demonstrated with traditional electron and light microscopic method~.~.~.'.'' The ability of anti-LNGFR antibodies to selectively identify a fibroblastic component of the BMS is somewhat surprising, owing to the prevalent interest of both the receptor and of the ligand in the biology of neural cells.'8 However, mesenchymal cell staining by anti-NGF-R MoAbs has been reported previo~sly.~"-~~ The staining we have obtained is specific for the presence of the low-affinity NGFR (p75NGFR)'8.'9: the two antibodies that we have used are well characterized and were obtained by separate immunization with different targets4'; both inhibit the binding of NGF to its receptor4' and react identically on BM preparations.
Furthermore, LNGFR was found to be present on normal and neoplastic mesenchymal and the appropriate molecule was biochemically precipitated2" with the Me20.4 antibody.
By RT-PCR, we have detected the RNA message for the LNGFR, both in vivo and in vitro samples of human BM. The sensitivity of the method is so high that in vivo periarteriolar nerve endings48 (and the present report) may theoretically account for the signal found in the BM aspirate. We think this possibility highly unlikely because organized structures such as vessels, etc, are underrepresented in aspirates and neuronal bodies are not found. In LTBMC the overwhelming population is made of fibroblasts and leukocytes and no neural structures have been described. The fibroblastic LNGFR+ve elements in BM aspirate and in LTBMC are most likely the source of the RNA found.
Our molecular data suggest that LNGFR on BM ARC is coupled with the NTRK I receptor." However, immunoprecipitation and/or immunostaining of the appropriate molecule on ARC must be done for confirmation.
The function of LNGFR on fibroblasts, the putative highaffinity companion receptor, and the ligand are unknown; the insertion and expression of the LNGFR gene alone on nonneuronal cells does not confer responsivity to the NGF on the recipient ~ells.4~ The high-affinity receptor NTRKl, but not the LNGFR, has been shown to be responsible for the physiologic effects of neurotrophic factors on transfected NIH-3T3 fibr0blasts.4~ However, the role of the LNGFR may be to "immobilize" or "clear"49 a growth factor and to present it to another cell type. as shown in the hematopoietic microenvironment for the proteoglycans of the BMS.50 A network of short range-acting growth-inducing factors may result in the specialized induction of organogenesis and indeed a morphogenic role of growth factor receptors has been forwarded for several molecules such as the homeotic sevenless gene," the retinoic acid receptor and related receptor family," and LNGFR.53.S4 We looked for a clue for such a function of LNGFR on fibroblasts by enumerating the LNGFR+ve stromal cells in the human body. Indeed, all LNGFR+ve fibroblastic cells share a position in close contact with sinusoidal endothelial cells, or are adventitial to vessels, tubular structures, or nerve trunks (epineurium), suggesting a selective affinity of LNGFR-bearing cells to support either the location or the growth of a specialized cell of a different origin.
The anti-LNGFR antibodies label the total ARC population; this antigen is also expressed on the earliest component For personal use only. on October 3, 2017. by guest www.bloodjournal.org From of the BMS found in the developing epiphyseal bone in the human f e t~s~,~~ and appear in the empty BM cavity before hematopoietic cells appear, as shown by the work of L. Weiss and L.T. Chen.55 Moreover, it can be found in in vitro grown BM, when the adherent layer is established.
The presence of LNGFR' stromal cells in in vitro reconstituted BM poses the question whether there is a stromal progenitor and if it has the NGF receptor on the membrane or if they represent BM-derived ARC adapted to the in vitro conditions. A cell surface marker for in vitro BM stromal progenitor has been recently described45 and used to reconstitute the stromal layer of LTBMC. We know that the ARC in vivo are Stro-1 negative. Cell separation studies are necessary to solve this point and the cell surface location of the LNGFR will help the collection and purification of ARC.
LNGFR+ ARC in the normal marrow had little and discontinuous extracellular matrix protein material adherent to their memb~-ane~~-~': most of it was collagen 111 (by immunohistochemistry and reticulin staining). Collagen IV was found at discrete sites along the ARC membranes12,16ss6 (and present report) at contact points with the endothelial cells, where, by triple IF, we could observe an interrupted trilaminar structure made of collagen IV", laminin, and ARC membrane.6.12,16.S6 The closeness of endothelial, ARC, and megakaryocyte at the sinusal border highlights the physiologic importance of the BM/blood barrier. Alterations of the barrier because of increased deposition of extracellular matrix or loss of function of one of the components (endothelium, ARC) causes impaired exit of the blood cells from the marrow. In myelofibrosis, platelet-derived fibrogenic factors are supposed to act on the stromal cells at the bamer ~i t e . '~~~ We documented and quantitated for the first time the variation of the ARC component of the BMS with a specific stain for these cells in various primary or metastatic BM diseases, known to be associated with f i b r~s i s . '~,~~ Not only endogenous fibrogenic cytokines, but exogenously administered growth factors (rhIL-3 and rhGM-CSF) induced an increase in LNGFR+ cells and reticulin deposition. A direct relationship between ARC and reticulin was observed, but not between endothelium and reticulin, despite an increase in the number of endothelial structures. However, we used for endothelial staining the CD34 antigen, which does not label the littoral cells. These latter form the bamer together with the ARC, and therefore we cannot exclude that a CD34-negative endothelial component may proliferate under fibrogenic stimuli and may contribute to increase both the reticulin and ARC. Moreover, subtle discrepancies between the variation of either LNGFR+ ARC or reticulin, as we observed in metastatic marrows and in rhIL-3-treated patients, may account for different mechanisms of the fibrotic process, depending on the cause of fibrosis.
The function of LNGFR on the ARC, a peculiar subset of stromal cells, is not yet elucidated, but its expression remains a useful phenotypic marker to identify ARC in diverse sites, some of which share the property of collecting hematopoietic cells (BM, spleen, lymph node) and interface with the parenchymal surface of endothelial cells in vascular sinuses in the BM, spleen, liver, and kidney.
